The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Interleukin-1 function and role in rheumatic disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., et al. (1992) · Nature · doi:10.1038/356768a0 · Cited by 2,572
Innate lymphoid cells — a proposal for uniform nomenclature
Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N. J., Mebius, R. E., et al. (2013) · Nature Reviews Immunology · doi:10.1038/nri3365 · Cited by 2,389
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945
Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., & Sallusto, F. (2007) · Nature Immunology · doi:10.1038/ni1496 · Cited by 1,857
Sutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330
Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
Chung, Y., Chang, S. H., Martinez, G. J., Yang, X. O., Nurieva, R., Kang, H. S., Ma, L., Watowich, S. S., Jetten, A. M., Tian, Q., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.02.007 · Cited by 1,199
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Schroder, K., Zhou, R., & Tschopp, J. (2010) · Science · doi:10.1126/science.1184003 · Cited by 1,134
Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.
Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., & Dinarello, C. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7907 · Cited by 1,042
The P2X7 Receptor: A Key Player in IL-1 Processing and Release
Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3877 · Cited by 1,025
An interleukin 1 like factor stimulates bone resorption in vitro
Gowen, M., Wood, D. D., Ihrie, E. J., McGuire, M. K. B., & Russell, R. G. G. (1983) · Nature · doi:10.1038/306378a0 · Cited by 1,012
Sutton, C., Brereton, C., Keogh, B., Mills, K. H. G., & Lavelle, E. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060285 · Cited by 1,010
Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines
Schauer, C., Janko, C., Munoz, L. E., Zhao, Y., Kienhöfer, D., Frey, B., Lell, M., Manger, B., Rech, J., Naschberger, E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3547 · Cited by 998
Self-citationAn Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
Aksentijevich, I., Masters, S. L., Ferguson, P. J., Dancey, P., Frenkel, J., van Royen-Kerkhoff, A., Laxer, R., Tedgård, U., Cowen, E. W., Pham, T.-H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807865 · Cited by 987
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S. K., Sims, J. E., & Mantovani, A. (1993) · Science · doi:10.1126/science.8332913 · Cited by 980
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
Goldbach-Mansky, R., Dailey, N. J., Canna, S. W., Gelabert, A., Jones, J., Rubin, B. I., Kim, H. J., Brewer, C., Zalewski, C., Wiggs, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055137 · Cited by 930
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Zielinski, C. E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., Monticelli, S., Lanzavecchia, A., & Sallusto, F. (2012) · Nature · doi:10.1038/nature10957 · Cited by 919
POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS
Gery, I., Gershon, R. K., & Waksman, B. H. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.1.128 · Cited by 907
Chen, C.-J., Kono, H., Golenbock, D., Reed, G., Akira, S., & Rock, K. L. (2007) · Nature Medicine · doi:10.1038/nm1603 · Cited by 876
Structure and mechanism of interleukin-lβ converting enzyme
Wilson, K. P., Black, J.-A. F., Thomson, J. A., Kim, E. E., Griffith, J. P., Navia, M. A., Murcko, M. A., Chambers, S. P., Aldape, R. A., Raybuck, S. A., et al. (1994) · Nature · doi:10.1038/370270a0 · Cited by 847
Cloning and expression of murine interleukin-1 cDNA in Escherichia coli
Lomedico, P. T., Gubler, U., Hellmann, C. P., Dukovich, M., Giri, J. G., Pan, Y.-C. E., Collier, K., Semionow, R., Chua, A. O., & Mizel, S. B. (1984) · Nature · doi:10.1038/312458a0 · Cited by 816
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
IL-1 mediates TNF-induced osteoclastogenesis
Wei, S., Kitaura, H., Zhou, P., Ross, F. P., & Teitelbaum, S. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523394 · Cited by 795
Netea, M. G., Nold-Petry, C. A., Nold, M. F., Joosten, L. A. B., Opitz, B., van der Meer, J. H. M., van de Veerdonk, F. L., Ferwerda, G., Heinhuis, B., Devesa, I., et al. (2009) · Blood · doi:10.1182/blood-2008-03-146720 · Cited by 792
Horai, R., Saijo, S., Tanioka, H., Nakae, S., Sudo, K., Okahara, A., Ikuse, T., Asano, M., & Iwakura, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.313 · Cited by 749
Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinra
Hawkins, P. N., Lachmann, H. J., Aganna, E., & McDermott, M. F. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20033 · Cited by 744
POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS
Gery, I., & Waksman, B. H. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.1.143 · Cited by 732
A pilot study of IL-1 inhibition by anakinra in acute gout
So, A., De Smedt, T., Revaz, S., & Tschopp, J. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2143 · Cited by 727
Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursor
Cosmi, L., De Palma, R., Santarlasci, V., Maggi, L., Capone, M., Frosali, F., Rodolico, G., Querci, V., Abbate, G., Angeli, R., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080397 · Cited by 706
Baracos, V., Rodemann, H. P., Dinarello, C. A., & Goldberg, A. L. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303103081002 · Cited by 690
Cohen, S., Hurd, E., Cush, J., Schiff, M., Weinblatt, M. E., Moreland, L. W., Kremer, J., Bear, M. B., Rich, W. J., & McCabe, D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10141 · Cited by 638
Kim, H. Y., Lee, H. J., Chang, Y.-J., Pichavant, M., Shore, S. A., Fitzgerald, K. A., Iwakura, Y., Israel, E., Bolger, K., Faul, J., et al. (2014) · Nature Medicine · doi:10.1038/nm.3423 · Cited by 635
Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue
Ferreira, S. H., Lorenzetti, B. B., Bristow, A. F., & Poole, S. (1988) · Nature · doi:10.1038/334698a0 · Cited by 624
Mizel, S. B., Dayer, J. M., Krane, S. M., & Mergenhagen, S. E. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2474 · Cited by 612
Self-citationCarter, D. B., Deibel, M. R., Dunn, C. J., Tomich, C.-S. C., Laborde, A. L., Slightom, J. L., Berger, A. E., Bienkowski, M. J., Sun, F. F., McEwan, R. N., et al. (1990) · Nature · doi:10.1038/344633a0 · Cited by 601
Hoffman, H. M., Throne, M. L., Amar, N. J., Sebai, M., Kivitz, A. J., Kavanaugh, A., Weinstein, S. P., Belomestnov, P., Yancopoulos, G. D., Stahl, N., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23687 · Cited by 577
Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes
Horton, J. E., Raisz, L. G., Simmons, H. A., Oppenheim, J. J., & Mergenhagen, S. E. (1972) · Science · doi:10.1126/science.177.4051.793 · Cited by 565
Treating inflammation by blocking interleukin-1 in humans
Dinarello, C. A., & van der Meer, J. W. M. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.008 · Cited by 549
Chevalier, X., Goupille, P., Beaulieu, A. D., Burch, F. X., Bensen, W. G., Conrozier, T., Loeuille, D., Kivitz, A. J., Silver, D., & Appleton, B. E. (2009) · Arthritis Care & Research · doi:10.1002/art.24096 · Cited by 533
Ridker, P. M., Howard, C. P., Walter, V., Everett, B., Libby, P., Hensen, J., & Thuren, T. (2012) · Circulation · doi:10.1161/circulationaha.112.122556 · Cited by 530
IL-1α and IL-1β Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation
Rider, P., Carmi, Y., Guttman, O., Braiman, A., Cohen, I., Voronov, E., White, M. R., Dinarello, C. A., & Apte, R. N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102048 · Cited by 522
(2008) · Arthritis & Rheumatism · doi:10.1002/art.23363 · Cited by 505
Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme
Afonina, I. S., Müller, C., Martin, S. J., & Beyaert, R. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.003 · Cited by 490
Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes.
Goldring, M. B., Birkhead, J. R., Suen, L. F., Yamin, R., Mizuno, S., Glowacki, J., Arbiser, J. L., & Apperley, J. F. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117595 · Cited by 477
Isolation of an interleukin‐1‐like factor from human joint effusions
Wood, D. D., Ihrie, E. J., Dinarello, C. A., & Cohen, P. L. (1983) · Arthritis & Rheumatism · doi:10.1002/art.1780260806 · Cited by 445
Elssner, A., Duncan, M., Gavrilin, M., & Wewers, M. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4987 · Cited by 425
Lequerré, T., Quartier, P., Rosellini, D., Alaoui, F., De Bandt, M., Mejjad, O., Kone-Paut, I., Michel, M., Dernis, E., Khellaf, M., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.076034 · Cited by 406
Chen, K. W., Groß, C. J., Sotomayor, F. V., Stacey, K. J., Tschopp, J., Sweet, M. J., & Schroder, K. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.028 · Cited by 405
Joosten, L. A. B., Helsen, M. M. A., van de Loo, F. A. J., & van den Berg, W. B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390513 · Cited by 400
Jiang, Y., Genant, H. K., Watt, I., Cobby, M., Bresnihan, B., Aitchison, R., & McCabe, D. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<1001::aid-anr7>3.0.co;2-p · Cited by 399
Kusano, K. (1998) · Endocrinology · doi:10.1210/en.139.3.1338 · Cited by 386
Gattorno, M., Piccini, A., Lasigliè, D., Tassi, S., Brisca, G., Carta, S., Delfino, L., Ferlito, F., Pelagatti, M. A., Caroli, F., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23437 · Cited by 382
van de Veerdonk, F. L., Stoeckman, A. K., Wu, G., Boeckermann, A. N., Azam, T., Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Hao, R., Kalabokis, V., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121534109 · Cited by 380
Pelletier, J., Caron, J. P., Evans, C., Robbins, P. D., Georgescu, H. I., Jovanovic, D., Fernandes, J. C., & Martel‐Pelletier, J. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400604 · Cited by 378
The Role of the Interleukin-1–Receptor Antagonist in Blocking Inflammation Mediated by Interleukin-1
Dinarello, C. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431011 · Cited by 373
Coeshott, C., Ohnemus, C., Pilyavskaya, A., Ross, S., Wieczorek, M., Kroona, H., Leimer, A. H., & Cheronis, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6261 · Cited by 365
CD161 is a marker of all human IL‐17‐producing T‐cell subsets and is induced by RORC
Maggi, L., Santarlasci, V., Capone, M., Peired, A., Frosali, F., Crome, S. Q., Querci, V., Fambrini, M., Liotta, F., Levings, M. K., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.200940257 · Cited by 362
Schlesinger, N., Alten, R. E., Bardin, T., Schumacher, H. R., Bloch, M., Gimona, A., Krammer, G., Murphy, V., Richard, D., & So, A. K. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200908 · Cited by 359
Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis
Lara-Tejero, M., Sutterwala, F. S., Ogura, Y., Grant, E. P., Bertin, J., Coyle, A. J., Flavell, R. A., & Galán, J. E. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060206 · Cited by 354
Dinarello, C., Arend, W., Sims, J., Smith, D., Blumberg, H., O'Neill, L., Goldbach-Mansky, R., Pizarro, T., Hoffman, H., Bufler, P., et al. (2010) · Nature Immunology · doi:10.1038/ni1110-973 · Cited by 351
Rapid responses to anakinra in patients with refractory adult‐onset Still's disease
Fitzgerald, A. A., LeClercq, S. A., Yan, A., Homik, J. E., & Dinarello, C. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21061 · Cited by 350
Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation
Blumberg, H., Dinh, H., Trueblood, E. S., Pretorius, J., Kugler, D., Weng, N., Kanaly, S. T., Towne, J. E., Willis, C. R., Kuechle, M. K., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070157 · Cited by 348
Familial autoinflammatory diseases: genetics, pathogenesis and treatment
Stojanov, S., & Kastner, D. L. (2005) · Current Opinion in Rheumatology · doi:10.1097/bor.0000174210.78449.6b · Cited by 346
Lindor, N. M., Arsenault, T. M., Solomon, H., Seidman, C. E., & McEvoy, M. T. (1997) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)63565-9 · Cited by 338
Cohen, I., Rider, P., Carmi, Y., Braiman, A., Dotan, S., White, M. R., Voronov, E., Martin, M. U., Dinarello, C. A., & Apte, R. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915018107 · Cited by 329
Joosten, L. A. B., Netea, M. G., Mylona, E., Koenders, M. I., Malireddi, R. K. S., Oosting, M., Stienstra, R., van de Veerdonk, F. L., Stalenhoef, A. F., Giamarellos‐Bourboulis, E. J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27667 · Cited by 328
Inflammasome-independent regulation of IL-1-family cytokines
Netea, M. G., van de Veerdonk, F. L., van der Meer, J. W. M., Dinarello, C. A., & Joosten, L. A. B. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112306 · Cited by 326
Gattorno, M., Pelagatti, M. A., Meini, A., Obici, L., Barcellona, R., Federici, S., Buoncompagni, A., Plebani, A., Merlini, G., & Martini, A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23475 · Cited by 312
Zwerina, J., Hayer, S., Tohidast‐Akrad, M., Bergmeister, H., Redlich, K., Feige, U., Dunstan, C., Kollias, G., Steiner, G., Smolen, J., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11487 · Cited by 307
Self-citationCohen, S. B., Moreland, L. W., Cush, J. J., Greenwald, M. W., Block, S., Shergy, W. J., Hanrahan, P. S., Kraishi, M. M., Patel, A., Sun, G., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016014 · Cited by 305
TNF-induced structural joint damage is mediated by IL-1
Zwerina, J., Redlich, K., Polzer, K., Joosten, L., Krönke, G., Distler, J., Hess, A., Pundt, N., Pap, T., Hoffmann, O., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610812104 · Cited by 304
Self-citationSugawara, S., Uehara, A., Nochi, T., Yamaguchi, T., Ueda, H., Sugiyama, A., Hanzawa, K., Kumagai, K., Okamura, H., & Takada, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6568 · Cited by 297
Roburn, M. (1964) · PubMed · Cited by 292
Interleukin‐1 Signaling Is Essential for Host Defense during Murine Pulmonary Tuberculosis
Juffermans, N. P., Florquin, S., Camoglio, L., Verbon, A., Kolk, A. H., Speelman, P., van Deventer, S. J. H., & van der Poll, T. (2000) · The Journal of Infectious Diseases · doi:10.1086/315771 · Cited by 278
Collagenase Production by Rheumatoid Synovial Cells: Stimulation by a Human Lymphocyte Factor
Dayer, J.-M., Russell, R. G. G., & Krane, S. M. (1977) · Science · doi:10.1126/science.188134 · Cited by 274
Self-citationHuman leukocytic pyrogen: purification and development of a radioimmunoassay.
Dinarello, C. A., Renfer, L., & Wolff, S. M. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.10.4624 · Cited by 272
Revised Nomenclature for Antigen-Nonspecific T Cell Proliferation and Helper Factors
(1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.6.2928 · Cited by 255
Lust, J. A., Lacy, M. Q., Zeldenrust, S. R., Dispenzieri, A., Gertz, M. A., Witzig, T. E., Kumar, S., Hayman, S. R., Russell, S. J., Buadi, F. K., et al. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.2.114 · Cited by 246
Cohen, S. B., Proudman, S., Kivitz, A. J., Burch, F. X., Donohue, J. P., Burstein, D., Sun, Y.-N., Banfield, C., Vincent, M. S., Ni, L., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3430 · Cited by 246
Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion
Chizzolini, C., Chicheportiche, R., Alvarez, M., de Rham, C., Roux-Lombard, P., Ferrari-Lacraz, S., & Dayer, J.-M. (2008) · Blood · doi:10.1182/blood-2008-05-155408 · Cited by 235
Self-citationRevised nomenclature for antigen-nonspecific T-cell proliferation and helper factors
Mizel, S. B., & Farrar, J. J. (1979) · Cellular Immunology · doi:10.1016/0008-8749(79)90139-4 · Cited by 234
Karmakar, M., Katsnelson, M., Malak, H. A., Greene, N. G., Howell, S. J., Hise, A. G., Camilli, A., Kadioglu, A., Dubyak, G. R., & Pearlman, E. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401624 · Cited by 233
DEMONSTRATION AND CHARACTERIZATION OF TWO DISTINCT HUMAN LEUKOCYTIC PYROGENS
Dinarello, C. A., Goldin, N. P., & Wolff, S. M. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.139.6.1369 · Cited by 229
Granzyme A is an interleukin 1 beta-converting enzyme.
Irmler, M., Hertig, S., MacDonald, H. R., Sadoul, R., Becherer, J. D., Proudfoot, A., Solari, R., & Tschopp, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1917 · Cited by 227
Brenner, M., Ruzicka, T., Plewig, G., Thomas, P., & Herzer, P. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09404.x · Cited by 225
Tyler, J. A. (1985) · Biochemical Journal · doi:10.1042/bj2270869 · Cited by 224
Nuki, G., Bresnihan, B., Bear, M. B., & McCabe, D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10578 · Cited by 222
In Vivo Transfer of Interleukin-1 Receptor Antagonist Gene in Osteoarthritic Rabbit Knee Joints
Fernandes, J., Tardif, G., Martel-Pelletier, J., Lascau-Coman, V., Dupuis, M., Moldovan, F., Sheppard, M., Krishnan, B. R., & Pelletier, J.-P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65368-0 · Cited by 219
Sodium Overload and Water Influx Activate the NALP3 Inflammasome
Schorn, C., Frey, B., Lauber, K., Janko, C., Strysio, M., Keppeler, H., Gaipl, U. S., Voll, R. E., Springer, E., Munoz, L. E., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139048 · Cited by 205
Self-citationChakraborty, A., Tannenbaum, S., Rordorf, C., Lowe, P. J., Floch, D., Gram, H., & Roy, S. (2012) · Clinical Pharmacokinetics · doi:10.2165/11599820-000000000-00000 · Cited by 199
Multiple Nod-Like Receptors Activate Caspase 1 during Listeria monocytogenes Infection
Warren, S. E., Mao, D. P., Rodriguez, A. E., Miao, E. A., & Aderem, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7558 · Cited by 176
Özören, N., Masumoto, J., Franchi, L., Kanneganti, T.-D., Body-Malapel, M., Ertürk, I., Jagirdar, R., Zhu, L., Inohara, N., Bertin, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4337 · Cited by 172
Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies
Cavalli, G., & Dinarello, C. A. (2015) · Rheumatology · doi:10.1093/rheumatology/kev269 · Cited by 171
Burger, D., Chicheportiche, R., Giri, J. G., & Dayer, J. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118045 · Cited by 159
Self-citationAlten, R., Gómez-Reino, J. J., Durez, P., Beaulieu, A. D., Sebba, A. I., Krammer, G., Preiss, R., Arulmani, U., Widmer, A., Gitton, X., et al. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-153 · Cited by 154
Attur, M. G., Patel, I. R., Patel, R. N., Abramson, S. B., & Amin, A. R. (1998) · PubMed · Cited by 150
Lovell, D. J., Bowyer, S. L., & Solinger, A. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20953 · Cited by 150
Ability of Human Leukocytic Pyrogen to Stimulate Brain Prostaglandin Synthesis In Vitro
Dinarello, C. A., & Bernheim, H. A. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb12544.x · Cited by 144
Seckinger, P., Williamson, K., Balavoine, J.-F., Mach, B., Mazzei, G. J., SHAW, A. R., & Dayer, J. M. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.5.1541 · Cited by 140
Self-citationKrause, K., Weller, K., Stefaniak, R., Wittkowski, H., Altrichter, S., Siebenhaar, F., Zuberbier, T., & Maurer, M. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02843.x · Cited by 134
Firestein, G. S., Berger, A. E., Tracey, D. E., et al. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.3.1054 · Cited by 128
Prieur, A., Griscelli, C., Kaufmann, M., & Dayer, J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91854-x · Cited by 122
Self-citationSchumacher, H. R., Evans, R. R., Saag, K. G., Clower, J. W., Jennings, W., Weinstein, S. P., Yancopoulos, G. D., Wang, J., & Terkeltaub, R. A. (2012) · Arthritis Care & Research · doi:10.1002/acr.21690 · Cited by 121
Regulated Intramembrane Proteolysis of the Interleukin-1 Receptor II by α-, β-, and γ-Secretase
Kuhn, P.-H., Marjaux, E., Imhof, A., De Strooper, B., Haass, C., & Lichtenthaler, S. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700356200 · Cited by 120
Rudloff, I., Godsell, J. D., Nold‐Petry, C. A., Harris, J., Hoi, A. Y.-B., Morand, E. F., & Nold, M. F. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39328 · Cited by 117
Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases
Ottaviani, S., Moltó, A., Ea, H., Neveu, S., Gill, G., Brunier, L., Palazzo, É., Meyer, O., Richette, P., Bardin, T., et al. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4303 · Cited by 116
Hensen, J., Howard, C. P., Walter, V., & Thuren, T. Y. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.07.003 · Cited by 115
Schiltz, C., Lioté, F., Prudhommeaux, F., Meunier, A., Champy, R., Callebert, J., & Bardin, T. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10326 · Cited by 114
Cailliez, M., Garaix, F., Rousset‐Rouvière, C., Bruno, D., Koné‐Paut, I., Sarles, J., Chabrol, B., & Tsimaratos, M. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0408-7 · Cited by 112
de Koning, H. D., Schalkwijk, J., van der Ven‐Jongekrijg, J., Stoffels, M., van der Meer, J. W. M., & Simon, A. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202192 · Cited by 111
Interleukin-1, tumor necrosis factor and their specific inhibitors.
Dayer, J. M., & Burger, D. (1994) · PubMed · Cited by 110
Self-citationKullberg, B. J., van 't Wout, J. W., & van Furth, R. (1990) · Infection and Immunity · doi:10.1128/iai.58.10.3319-3324.1990 · Cited by 105
Re, F., Sironi, M., Muzio, M., Matteucci, C., Introna, M., Orlando, S., Pentón‐Rol, G., Dower, S., Sims, J. E., Colotta, F., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1841 · Cited by 102
Efficacy of Anakinra in Refractory Adult-Onset Still's Disease
Ortiz-Sanjuán, F. M., Blanco, R., Riancho‐Zarrabeitia, L., Castañeda, S., Olivé, A., Riveros, A., Velloso-Feijoó, M. L., Narváez, J., Moleón, I. J., Maiz, O., et al. (2015) · Medicine · doi:10.1097/md.0000000000001554 · Cited by 101
Mitha, E., Schumacher, H. R., Fouche, L. F., Luo, S., Weinstein, S. P., Yancopoulos, G. D., Wang, J., King-Davis, S., & Evans, R. R. (2013) · Rheumatology · doi:10.1093/rheumatology/ket114 · Cited by 100
Kerkhof, H. J. M., Doherty, M., Arden, N., Abramson, S. B., Attur, M. G., Bos, S. D., Cooper, C. C., Dennison, E. M., Doherty, S. A., Εvangelou, Ε., et al. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.12.003 · Cited by 99
XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1β-mediated diseases
Owyang, A. M., Issafras, H., Corbin, J., Ahluwalia, K., Larsen, P., Pongo, E., Handa, M., Horwitz, A. H., Roell, M. K., Haak‐Frendscho, M., et al. (2011) · mAbs · doi:10.4161/mabs.3.1.13989 · Cited by 93
Rynne, M., Maclean, C., Bybee, A., McDermott, M. F., & Emery, P. E. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038091 · Cited by 86
Bresnihan, B. (2001) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2001.23701 · Cited by 85
Meprin A and meprin α generate biologically functional IL-1β from pro-IL-1β
Herzog, C., Haun, R. S., Kaushal, V., Mayeux, P. R., Shah, S. V., & Kaushal, G. P. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.161 · Cited by 81
Treatment of Acute Gouty Arthritis in Complex Hospitalized Patients With Anakinra
Ghosh, P., Cho, M., Rawat, G., Simkin, P. A., & Gardner, G. C. (2013) · Arthritis Care & Research · doi:10.1002/acr.21989 · Cited by 80
Dayer, J. (2004) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2003.09.009 · Cited by 78
Self-citationAttur, M. G., Wang, H.-Y., Kraus, V. B., Bukowski, J. F., Aziz, N., Krasnokutsky, S., Samuels, J., Greenberg, J., McDaniel, G. E., Abramson, S. B., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.113043 · Cited by 75
Koch, A. E., Kunkel, S. L., Chensue, S. W., Haines, G. K., & Strieter, R. M. (1992) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(92)90243-h · Cited by 71
Anti–interleukin-1 therapy in rheumatic diseases
Dayer, J., Feige, U., Edwards, C. K., & Burger, D. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200105000-00004 · Cited by 67
Self-citationSynovial immunopathology in haemochromatosis arthropathy
Heiland, G. R., Aigner, E., Dallos, T., Sahinbegovic, E., Krenn, V., Thaler, C., Weiss, G., Distler, J. H., Datz, C., Schett, G., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.120204 · Cited by 64
Self-citationAn Overview of Interleukin-1 Receptor Antagonist, Anakinra, in the Treatment of Cutaneous Diseases
Pazyar, N., Feily, A., & Yaghoobi, R. (2012) · Current Clinical Pharmacology · doi:10.2174/157488412803305821 · Cited by 60
Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA)
Ohlsson, V., Baildam, E. M., Foster, H., Jandial, S., Pain, C. E., Strike, H., & Ramanan, A. V. (2007) · Lara D. Veeken · doi:10.1093/rheumatology/ken030 · Cited by 55
Prostaglandin E2: igniting the fire
Chizzolini, C., & Brembilla, N. C. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.56 · Cited by 43
Coleman, K., Gudjonsson, J. E., & Stecher, M. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.5391 · Cited by 26
Efficacy of anakinra in articular chondrocalcinosis: Report of three cases
Couderc, M., Mathieu, S., Glace, B., & Soubrier, M. (2012) · Joint Bone Spine · doi:10.1016/j.jbspin.2011.12.017 · Cited by 24
Erosion healing in rheumatoid arthritis after anakinra treatment
Rau, R., Sander, O., & Wassenberg, S. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.7.671 · Cited by 9
Romas (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200004)43:4
Cited by
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
Schwartz, D. M., Kanno, Y., Villarino, A., Ward, M., Gadina, M., & O'Shea, J. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.201 · Cited by 1,266
Physiological functions and pathogenic potential of uric acid: A review
El Ridi, R., & Tallima, H. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2017.03.003 · Cited by 542
Cytokines in rheumatoid arthritis — shaping the immunological landscape
McInnes, I. B., Buckley, C. D., & Isaacs, J. D. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.171 · Cited by 504
SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation
Pan, P., Shen, M., Yu, Z., Ge, W., Chen, K., Tian, M., Xiao, F., Wang, Z., Wang, J., Jia, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25015-6 · Cited by 501
Skeletal Muscle as Potential Central Link between Sarcopenia and Immune Senescence
Nelke, C., Dziewas, R., Minnerup, J., Meuth, S. G., & Ruck, T. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.10.034 · Cited by 437
Metadata
- Authors
- Schett, G., Dayer, J.-M., & Manger, B.
- Venue
- Nature Reviews Rheumatology
- Published
- 2015-12-10
- Volume
- 12
- Issue
- 1
- Pages
- 14-24
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- OpenAlex
- W2239738050
- Cited by
- 279
- References
- 136
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.